A detailed history of Tower View Investment Management & Research LLC transactions in Pfizer Inc stock. As of the latest transaction made, Tower View Investment Management & Research LLC holds 1,123 shares of PFE stock, worth $29,894. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,123
Previous 1,107 1.45%
Holding current value
$29,894
Previous $30,000 6.67%
% of portfolio
0.02%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$27.7 - $31.39 $443 - $502
16 Added 1.45%
1,123 $32,000
Q2 2024

Jul 26, 2024

BUY
$25.26 - $29.6 $429 - $503
17 Added 1.56%
1,107 $30,000
Q1 2024

Apr 29, 2024

BUY
$25.89 - $29.73 $440 - $505
17 Added 1.58%
1,090 $30,000
Q4 2023

Feb 06, 2024

SELL
$26.13 - $33.94 $22,027 - $28,611
-843 Reduced 44.0%
1,073 $31,000
Q3 2023

Oct 31, 2023

BUY
$32.09 - $37.51 $27,918 - $32,633
870 Added 83.17%
1,916 $64,000
Q2 2023

Jul 31, 2023

BUY
$36.12 - $41.79 $397 - $459
11 Added 1.06%
1,046 $38,000
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $393 - $512
10 Added 0.98%
1,035 $42,000
Q4 2022

Feb 13, 2023

BUY
$41.75 - $54.5 $334 - $436
8 Added 0.79%
1,025 $53,000
Q3 2022

Nov 15, 2022

BUY
$43.76 - $53.42 $393 - $480
9 Added 0.89%
1,017 $45,000
Q2 2022

Aug 08, 2022

BUY
$46.53 - $55.17 $372 - $441
8 Added 0.8%
1,008 $53,000
Q3 2021

Nov 08, 2021

BUY
$39.25 - $50.42 $39,250 - $50,420
1,000 New
1,000 $43,000
Q4 2018

Jan 04, 2019

SELL
$38.47 - $43.86 $53,858 - $61,404
-1,400 Closed
0 $0
Q1 2018

Apr 10, 2018

SELL
$31.91 - $37.02 $1,755 - $2,036
-55 Reduced 3.78%
1,400 $50,000
Q4 2017

Jan 24, 2018

BUY
$33.26 - $35.29 $48,393 - $51,346
1,455
1,455 $53,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Tower View Investment Management & Research LLC Portfolio

Follow Tower View Investment Management & Research LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower View Investment Management & Research LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tower View Investment Management & Research LLC with notifications on news.